TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

Short TMDX slightly under 86, target n/a, stop loss @ 86.25 Check the time stamp on this data. Updated AI-Generated Signals ...

In recent trading, TransMedics Group Inc (TMDX) stock price has shown some volatility, fluctuating 10.37% over the last five trades and -3.29% over the past 30 trades. This represents a notable shift ...

Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.

TransMedics Gr TMDX has outperformed the market over the past 5 years by 15.56% on an annualized basis producing an average ...